Opinion|Videos|July 2, 2025
Reshaping Rx: Navigating 2025 Drug Pricing Policies—Recording
Author(s)Laura Joszt, MA
Fact checked by: Maggie L. Shaw
In a webinar, panelists discuss Trump's 2025 drug pricing policies, focusing on the Most Favored Nation order, pharmacy benefit manager reform, and implications for manufacturers and patients.
Advertisement
Advertisement
During a conversation on the Trump administration’s 2025 drug pricing policies, panelists discussed the implications of the Most Favored Nation policy, the broader context of drug pricing reforms, and efforts to address pharmacy benefit manager (PBM) reform through greater transparency.
Advertisement
Advertisement